Skip to content

The effect of dapagliflozin on contrast induced nephropathy

Effect of dapagliflozin on contrast-induced nephropathy after computed tomography angiography

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098100
Enrollment
Unknown
Registered
2025-03-03
Start date
2023-03-05
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contrast-Induced Nephropathy

Interventions

Sponsors

The Second Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Main clinical symptoms include chest tightness, arrhythmia, angina pectoris, etc; 2. Individuals without expression or mental disorders and with good compliance; 3. Age range of 18-80 years old 4. The patient and their family members are informed and have signed a consent form;

Exclusion criteria

Exclusion criteria: 1.Individuals with a history of coronary artery bypass or other cardiac surgeries; 2.Individuals allergic to iodine contrast agents; 3.Check for unclear images; 4.Patients with incomplete clinical data or those who withdraw from the group midway due to various reasons; Renal transplant or end-stage renal disease patients who are allergic to contrast agents and require dialysis.

Design outcomes

Primary

MeasureTime frame
Scr;

Countries

China

Contacts

Public ContactBiming Zhan

The Second Affiliated Hospital of Nanchang University

drzhanbiming@163.com+86 15270881085

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026